EIM
BVS icon

Essex Investment Management’s Bioventus BVS Stock Holding History

Essex Investment Management’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.51M Buy
603,258
+215,372
+56% +$1.81M 0.87% 32
2025
Q4 		$2.89M Buy
+387,886
New +$2.79M 0.44% 88

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Essex Investment Management's BVS Position: Q1 2026 in Review

Essex Investment Management increased its Bioventus (BVS) stake by 56% in Q1 2026, buying an estimated $1.81M and bringing the position to 603,258 shares worth $5.51M. The position accounts for 0.87% of the portfolio, ranked #32.

Essex Investment Management first reported a position in BVS in Q4 2025 and has held it in 2 quarters since. 157 funds tracked by Wall St. Rank hold BVS as of Q1 2026.

  • Essex Investment Management held 603,258 shares of Bioventus worth $5.51M as of Q1 2026.
  • Essex Investment Management bought 215,372 Bioventus shares in Q1 2026, an estimated $1.81M.
  • Bioventus made up 0.87% of Essex Investment Management's portfolio in Q1 2026, its #32 holding.
  • Essex Investment Management first reported a position in Bioventus in Q4 2025 and has held it in 2 quarters since.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q1 2026.

Based on Essex Investment Management's 13F filing for Q1 2026, filed 11 May 2026.